Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janaki Amin

Showing results (91-100 of 196) with videos related to

Pageof 20
Sort By:
The Journal of Infectious Diseases|September 4, 2004
Clearance of hepatitis C virus after newly acquired infection in injection drug usersMarianne Jauncey, Joanne M Micallef, Stuart Gilmour, et al.
Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002)|April 22, 2011
The Clinical Significance of CD4 Counts in Asian and Caucasian HIV-Infected Populations: Results from TAHOD and AHODAmit C Achhra, Jialun Zhou, Jun Yong Choi, et al.
JAMA|July 4, 2002
Abacavir substitution for nucleoside analogs in patients with HIV lipoatrophy: a randomized trialAndrew Carr, Cassy Workman, Don E Smith, et al.
The Journal of Antimicrobial Chemotherapy|December 22, 2010
Pharmacokinetics of plasma lopinavir/ritonavir following the administration of 400/100 mg, 200/150 mg and 200/50 mg twice daily in HIV-negative volunteersAkil Jackson, Andrew Hill, Rebekah Puls, et al.
AIDS (London, England)|July 1, 2010
Immunodeficiency and the risk of serious clinical endpoints in a well studied cohort of treated HIV-infected patientsAmit C Achhra, Janaki Amin, Matthew G Law, et al.
Journal of Medical Virology|July 22, 2014
Dynamics of HCV RNA levels during acute hepatitis C virus infectionBehzad Hajarizadeh, Jason Grebely, Tanya Applegate, et al.
BMC Public Health|March 29, 2025
COVID-19 symptomatic community illness, hospitalization, and death burden across all ages - New South Wales, Australia, May 2021-July 2022Kelsey M Sumner, Sandra Carlson, Benjamin Elton, et al.
AIDS (London, England)|April 21, 2004
Reversibility of lipoatrophy in HIV-infected patients 2 years after switching from a thymidine analogue to abacavir: the MITOX Extension StudyAllison Martin, Don E Smith, Andrew Carr, et al.
Patient Education and Counseling|June 4, 2023
Readability and beyond - Health literacy and numeracy and COVID-19 communications in early childhood education: Are we communicating effectively?Maria R Dahm, Rebecca Bull, Lauren Sadow, et al.
The Medical Journal of Australia|April 19, 2011
Predictors of deferral of treatment for hepatitis C infection in Australian clinicsHeather F Gidding, Matthew G Law, Janaki Amin, et al.
Pageof 20

Showing results (91-100 of 196) with videos related to

Sort By:
Pageof 20
The Journal of Infectious Diseases|September 4, 2004
Clearance of hepatitis C virus after newly acquired infection in injection drug usersMarianne Jauncey, Joanne M Micallef, Stuart Gilmour, et al.
Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002)|April 22, 2011
The Clinical Significance of CD4 Counts in Asian and Caucasian HIV-Infected Populations: Results from TAHOD and AHODAmit C Achhra, Jialun Zhou, Jun Yong Choi, et al.
JAMA|July 4, 2002
Abacavir substitution for nucleoside analogs in patients with HIV lipoatrophy: a randomized trialAndrew Carr, Cassy Workman, Don E Smith, et al.
The Journal of Antimicrobial Chemotherapy|December 22, 2010
Pharmacokinetics of plasma lopinavir/ritonavir following the administration of 400/100 mg, 200/150 mg and 200/50 mg twice daily in HIV-negative volunteersAkil Jackson, Andrew Hill, Rebekah Puls, et al.
AIDS (London, England)|July 1, 2010
Immunodeficiency and the risk of serious clinical endpoints in a well studied cohort of treated HIV-infected patientsAmit C Achhra, Janaki Amin, Matthew G Law, et al.
Journal of Medical Virology|July 22, 2014
Dynamics of HCV RNA levels during acute hepatitis C virus infectionBehzad Hajarizadeh, Jason Grebely, Tanya Applegate, et al.
BMC Public Health|March 29, 2025
COVID-19 symptomatic community illness, hospitalization, and death burden across all ages - New South Wales, Australia, May 2021-July 2022Kelsey M Sumner, Sandra Carlson, Benjamin Elton, et al.
AIDS (London, England)|April 21, 2004
Reversibility of lipoatrophy in HIV-infected patients 2 years after switching from a thymidine analogue to abacavir: the MITOX Extension StudyAllison Martin, Don E Smith, Andrew Carr, et al.
Patient Education and Counseling|June 4, 2023
Readability and beyond - Health literacy and numeracy and COVID-19 communications in early childhood education: Are we communicating effectively?Maria R Dahm, Rebecca Bull, Lauren Sadow, et al.
The Medical Journal of Australia|April 19, 2011
Predictors of deferral of treatment for hepatitis C infection in Australian clinicsHeather F Gidding, Matthew G Law, Janaki Amin, et al.
Pageof 20